FR2290220B2 - - Google Patents

Info

Publication number
FR2290220B2
FR2290220B2 FR7436736A FR7436736A FR2290220B2 FR 2290220 B2 FR2290220 B2 FR 2290220B2 FR 7436736 A FR7436736 A FR 7436736A FR 7436736 A FR7436736 A FR 7436736A FR 2290220 B2 FR2290220 B2 FR 2290220B2
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7436736A
Other languages
French (fr)
Other versions
FR2290220A2 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Original Assignee
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur de Lille filed Critical Institut Pasteur de Lille
Priority to FR7436736A priority Critical patent/FR2290220A2/fr
Priority to OA55421A priority patent/OA04947A/xx
Publication of FR2290220A2 publication Critical patent/FR2290220A2/fr
Application granted granted Critical
Publication of FR2290220B2 publication Critical patent/FR2290220B2/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR7436736A 1974-02-26 1974-11-05 Nouveau vaccin antirabique Granted FR2290220A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR7436736A FR2290220A2 (fr) 1974-11-05 1974-11-05 Nouveau vaccin antirabique
OA55421A OA04947A (fr) 1974-02-26 1975-02-20 Procédé pour l'obtention d'un nouveau vaccin antirabique.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7436736A FR2290220A2 (fr) 1974-11-05 1974-11-05 Nouveau vaccin antirabique

Publications (2)

Publication Number Publication Date
FR2290220A2 FR2290220A2 (fr) 1976-06-04
FR2290220B2 true FR2290220B2 (US07642317-20100105-C00010.png) 1978-07-21

Family

ID=9144679

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7436736A Granted FR2290220A2 (fr) 1974-02-26 1974-11-05 Nouveau vaccin antirabique

Country Status (1)

Country Link
FR (1) FR2290220A2 (US07642317-20100105-C00010.png)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4347239A (en) 1980-07-30 1982-08-31 Norden Laboratories, Inc. Inactivated rabies vaccine for veterinary use
US4429045A (en) 1980-07-30 1984-01-31 Norden Laboratories, Inc. Rabies virus adapted for growth in swine testicle cell culture

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3585266A (en) * 1969-02-24 1971-06-15 Dow Chemical Co Live rabies virus vaccine and method for the production thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4347239A (en) 1980-07-30 1982-08-31 Norden Laboratories, Inc. Inactivated rabies vaccine for veterinary use
US4429045A (en) 1980-07-30 1984-01-31 Norden Laboratories, Inc. Rabies virus adapted for growth in swine testicle cell culture

Also Published As

Publication number Publication date
FR2290220A2 (fr) 1976-06-04

Similar Documents

Publication Publication Date Title
FR2277682B1 (US07642317-20100105-C00010.png)
FR2272442A1 (US07642317-20100105-C00010.png)
FR2266269B1 (US07642317-20100105-C00010.png)
FR2257079B1 (US07642317-20100105-C00010.png)
FR2290220B2 (US07642317-20100105-C00010.png)
JPS50102714U (US07642317-20100105-C00010.png)
AU495920B2 (US07642317-20100105-C00010.png)
DK569374A (US07642317-20100105-C00010.png)
AU7099174A (US07642317-20100105-C00010.png)
AU7138274A (US07642317-20100105-C00010.png)
BG21632A1 (US07642317-20100105-C00010.png)
BG20987A1 (US07642317-20100105-C00010.png)
AU481082A (US07642317-20100105-C00010.png)
CH585098A5 (US07642317-20100105-C00010.png)
CH1357474A4 (US07642317-20100105-C00010.png)
CH1107074A4 (US07642317-20100105-C00010.png)
BG26152A1 (US07642317-20100105-C00010.png)
BG23188A1 (US07642317-20100105-C00010.png)
BG22732A1 (US07642317-20100105-C00010.png)
BG22484A1 (US07642317-20100105-C00010.png)
BG22309A1 (US07642317-20100105-C00010.png)
BG22203A1 (US07642317-20100105-C00010.png)
BG22011A1 (US07642317-20100105-C00010.png)
BG21805A1 (US07642317-20100105-C00010.png)
DD116209A1 (US07642317-20100105-C00010.png)